PLx Pharma Winddown (PLXPQ) 10-K2021 FY Annual report

Filed: 11 Mar 22, 7:30am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absorbed, acetylsalicylic, adhere, aggregometry, al, Amazon, analyzing, API, arachidonic, armed, arriving, assimilation, backup, batch, began, bottle, broader, Broker, campaign, carrier, continental, cooperative, count, coupon, crossover, cyber, cybersecurity, de, deploy, destination, driven, earn, ecommerce, economy, element, entail, feel, flexibility, FOB, formatted, Franchi, freight, grocery, Guard, head, immaterial, inbound, incident, Inline, isloated, Language, lieu, lifesaving, lining, lipid, lipidic, macroeconomic, malfeasance, margin, maximize, media, NaN, nationwide, nonrenewal, notwithstanding, outbound, overallotment, payoff, Pharmacodynamic, Pharmacokinetic, phishing, picked, plain, poster, potent, potentialcollaboration, preassociation, procure, prompt, promptly, proportionally, quantity, randomized, resell, reserve, RESERVED, retention, RJW, Russia, sabotage, screening, shift, ship, shipped, shipping, slotting, software, sophisticated, sublessor, suppressed, suppression, Supreme, television, thousand, Transcatheter, trend, Ukraine, unaffected, unpredictable, unsatisfied, variance, verification, virtual, vulnerable, Walmart, warehouse, warehousing, weaken, weakening, worsening

Removed: accruing, acting, attainment, bicarbonate, bile, bloating, borrow, building, cancellation, capability, closing, coating, contemporary, corrosive, deadline, differential, duodenum, dyspepsia, fatty, focusing, impermeable, insoluble, Instance, labile, Linkbase, mandate, minimal, modify, owe, pancreatic, par, Pfizer, physiochemical, polymer, proton, pump, qualifying, registering, relying, route, Schema, startup, strict, surface, surrendered, tablet, Taxonomy, TIA, TM, ulceration

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated PLXPQ transcripts

PLXPQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statements No. 333-258540, No. 333-251554, No. 333-239547, No. 333-204830, No. 333-230478 and No. 333-230550 on Form S-3 and Registration Statements No. 333-261258, No. 333-196824 and No. 333-212421 on Form S-8 of PLx Pharma Inc. of our report dated March 11, 2022, with respect to our audits of the consolidated financial statements of PLx Pharma Inc. as of December 31, 2021 and 2020 and for each of the two years in the period ended December 31, 2021, which report is included in this Annual Report on Form 10-K of PLx Pharma Inc. for the year ended December 31, 2021.

/s/ Marcum LLP

Marcum LLP

New York, NY

March 11, 2022